Suntrust Banks’s DexCom DXCM Stock Holding History

Suntrust Banks’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.69M	Buy	45,256 +22,584	+100%	+$877K	0.01%	629
2019 Q2	$849K	Buy	22,672 +92	+0.4%	+$2.89K	﹤0.01%	818
2019 Q1	$672K	Buy	22,580 +100	+0.4%	+$3.51K	﹤0.01%	872
2018 Q4	$673K	Sell	22,480 -1,944	-8%	-$61.7K	﹤0.01%	802
2018 Q3	$873K	Sell	24,424 -296	-1%	-$9.18K	﹤0.01%	774
2018 Q2	$587K	Sell	24,720 -11,300	-31%	-$240K	﹤0.01%	877
2018 Q1	$668K	Buy	+36,020	New	+$533K	﹤0.01%	822
2017 Q4	–	Sell	-43,876	Closed	-$536K	–	1255
2017 Q3	$536K	Sell	43,876 -14,652	-25%	-$259K	﹤0.01%	864
2017 Q2	$1.07M	Buy	58,528 +5,448	+10%	+$101K	0.01%	641
2017 Q1	$1.12M	Sell	53,080 -5,616	-10%	-$110K	0.01%	624
2016 Q4	$875K	Buy	58,696 +27,828	+90%	+$493K	0.01%	817
2016 Q3	$675K	Buy	30,868 +19,196	+164%	+$427K	﹤0.01%	860
2016 Q2	$230K	Buy	+11,672	New	+$199K	﹤0.01%	1312
2014 Q2	–	Sell	-24,212	Closed	-$250K	–	1470
2014 Q1	$250K	Hold	24,212	–	–	﹤0.01%	1675
2013 Q4	$214K	Buy	+24,212	New	+$192K	﹤0.01%	1674

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Suntrust Banks's DXCM Position: Q3 2019 in Review

Suntrust Banks increased its DexCom (DXCM) stake by 100% in Q3 2019, buying an estimated $877K and bringing the position to 45,256 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #629.

Suntrust Banks first reported a position in DXCM in Q4 2013 and has held it in 15 quarters since. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

Suntrust Banks held 45,256 shares of DexCom worth $1.69M as of Q3 2019.
Suntrust Banks bought 22,584 DexCom shares in Q3 2019, an estimated $877K.
DexCom made up 0.01% of Suntrust Banks's portfolio in Q3 2019, its #629 holding.
Suntrust Banks first reported a position in DexCom in Q4 2013 and has held it in 15 quarters since.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.